Marcel de Brito van Velze

Marcel de Brito van Velze

Auto-generated profile, based on publicly available information

Marcel de Brito van Velze

Affiliation Department of Neuroscience, Erasmus Medical Center, Rotterdam, The Netherlands

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2021 in PLOS Biology
Verified
Journal Article
Open access
PDF file
MOMartina Proietti Onori
Martina Proietti Onori
LKLinda M. C. Koene
Linda M. C. Koene
CSCarmen B. Schäfer
Carmen B. Schäfer
MNMark Nellist
Mark Nellist
MVMarcel de Brito van Velze
Marcel de Brito van Velze
GWGeeske M. van Woerden
Geeske M. van Woerden
Hyperactivation of the mammalian target of rapamycin (mTOR) pathway can cause malformation of cortical development (MCD) with associated epilepsy and intellectual disability (ID) through a yet unknown mechanism. Here, we made use of the recently identified dominant-active mutation inRas Homolog Enriched in Brain 1(RHEB), RHEBp.P37L, to gain insight in the mechanism underlying the epilepsy caused by hyperactivation of the mTOR pathway. Focal expression of RHEBp.P37L in mouse somatosensory cortex (SScx) results in an MCD-like phenotype, with increased mTOR signaling, ectopic localization of neurons, and reliable generalized seizures. We show that in this model, the mTOR-dependent seizures are caused by enhanced axonal connectivity, causing hyperexcitability of distally connected neurons. Indeed, blocking axonal vesicle release from the RHEBp.P37L neurons alone completely stopped the seizures and normalized the hyperexcitability of the distally connected neurons. These results provide new evidence of the extent of anatomical and physiological abnormalities caused by mTOR hyperactivity, beyond local malformations, which can lead to generalized epilepsy.